Abstract
Five-year survival after the diagnosis of non-small cell lung cancer is the most common benchmark used to evaluate long-term survival. Data on survival beyond 5 years are sparse. We sought to elucidate variables affecting 10- to 18-year survival. A total of 31,206 patients alive at least 5 years after diagnosis of non-small cell lung cancer who were registered in the Surveillance, Epidemiology, and End Results database from 1988 to 2001 were examined. Primary end points were disease-specific survival and overall survival. Survival analysis was performed with Kaplan-Meier estimates, multivariable Cox proportional hazards regression, and competing risk models. Overall survival at 10, 15, and 18 years was 55.4%, 33.1%, and 24.3%, respectively. Disease-specific survival at 10, 15, and 18 years was 76.6%, 65.4%, and 59.4%, respectively. In multivariable regression analysis, squamous cell cancers had a disease-specific survival advantage (hazard ratio, 0.88; P < .0001) but an overall survival disadvantage (hazard ratio, 1.082; P = .0002) compared with adenocarcinoma. Pneumonectomy (hazard ratio, 0.44) and lobectomy (hazard ratio, 0.474) had improved disease-specific survival compared with no surgery (P < .0001). Left-sided tumors (ha...Continue Reading
References
Mar 15, 1984·Cancer·B K TemeckN Martini
Apr 30, 1993·Statistics in Medicine·M S Pepe, M Mori
Dec 1, 1995·Cancer·C ZippinB F Hankey
Dec 1, 1995·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·H WadaS Hitomi
Sep 25, 1998·Journal of the National Cancer Institute·B E Johnson
Dec 31, 1998·The Journal of Thoracic and Cardiovascular Surgery·N MartiniR J Ginsberg
Feb 21, 2002·The European Respiratory Journal·J P van MeerbeeckM L Vos de Wael
Oct 27, 2006·The New England Journal of Medicine·UNKNOWN International Early Lung Cancer Action Program InvestigatorsOlli S Miettinen
Mar 20, 2010·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·UNKNOWN Alzheimer's Association
Apr 15, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Taofeek K OwonikokoChandra P Belani
Sep 28, 2010·The Annals of Thoracic Surgery·Sudish C MurthyEugene H Blackstone
Citations
Apr 27, 2013·Journal of Cardiothoracic Surgery·Kazuto OhtakaYoshiro Matsui
Feb 6, 2013·Theranostics·Ori WaldUzi Izhar
Aug 12, 2014·PloS One·Jinxiang XiEn-Bing Lin
Aug 27, 2014·Annals of Surgical Oncology·Jae Seon EoYoung Ho Choi
Apr 23, 2013·Cancer·Suresh Senan
Nov 7, 2015·The Annals of Thoracic Surgery·Ken KodamaKeiko Kuriyama
Aug 1, 2012·Clinical Lung Cancer·David A Palma, Suresh Senan
Aug 29, 2012·The Journal of Thoracic and Cardiovascular Surgery·Duha FahhamOri Wald
Feb 13, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M L G Janssen-HeijnenH J M Groen
Jun 9, 2016·Chemico-biological Interactions·Boondaree Siriwarin, Natthida Weerapreeyakul
Sep 5, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sashendra Senthi, Suresh Senan
Apr 14, 2017·Current Opinion in Pulmonary Medicine·Ching-Fei Chang, Michael Gould
Jun 18, 2017·Expert Review of Anticancer Therapy·Omar Abdel-Rahman
Jul 21, 2020·Cancer Science·Keiko OhginoKenzo Soejima
Aug 2, 2020·International Journal of Cancer. Journal International Du Cancer·Jung Eun YooKyu-Won Jung
Apr 21, 2017·Current Medical Research and Opinion·Omar Abdel-Rahman
Apr 5, 2020·Cancers·Joerg LindenmannFreyja Maria Smolle-Juettner
Apr 8, 2020·Journal of Oncology·Vladimir JurisicNataša Djordjević
Oct 6, 2017·Journal of Cancer Research and Clinical Oncology·Shenhai WeiLimin Liu
Jan 16, 2021·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hossein BorghaeiJulie Brahmer
Jan 31, 2021·Cancer Treatment and Research Communications·W M SzejniukO D Røe
Mar 19, 2021·Respiratory Medicine Case Reports·Chaiyoung LeeHojoong Kim
Aug 3, 2021·Frontiers in Medicine·Haisheng YouSiying Chen